Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment  Derek Gillen, Angela A. Wirz, Kenneth E.L.

Slides:



Advertisements
Similar presentations
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
Advertisements

Overview and pathogenesis of celiac disease Martin F. Kagnoff Gastroenterology Volume 128, Issue 4, Pages S10-S18 (April 2005) DOI: /j.gastro
Volume 121, Issue 4, Pages (October 2001)
Volume 145, Issue 4, Pages (October 2013)
Randomized controlled trial of biofeedback for fecal incontinence
Volume 133, Issue 1, Pages (July 2007)
Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects  Paolo L. Peghini, Philip O. Katz, Donald.
Gastrin in Gastrointestinal Diseases
Bile Acid Synthesis in Humans Has a Rapid Diurnal Variation That Is Asynchronous With Cholesterol Synthesis  Cecilia Gälman, Bo Angelin, Mats Rudling 
Helicobacter pylori Mayo Clinic Proceedings
This month in Gastroenterology
Simon P. Dunlop, Nicholas S. Coleman, Elaine Blackshaw, Alan C
Volume 137, Issue 5, Pages e2 (November 2009)
Jesús Rivera–Nieves, María T. Abreu  Gastroenterology 
Outcomes Among Living Liver Donors
Covering the Cover Gastroenterology
Volume 126, Issue 4, Pages (April 2004)
Volume 129, Issue 5, Pages (November 2005)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
David J. Brenner, Eric J. Hall, Rochelle E. Curtis, Elaine Ron 
The Functional Gastrointestinal Disorders and the Rome III Process
Volume 129, Issue 6, Pages (December 2005)
Volume 115, Issue 1, Pages (July 1998)
Covering the Cover Gastroenterology
Volume 143, Issue 4, Pages (October 2012)
Helicobacter pylori Eradication and Metachronous Gastric Cancer
Volume 128, Issue 7, Pages (June 2005)
Craig Mowat, Andrew Carswell, Angela Wirz, Kenneth E.L. McColl 
Treatment of Helicobacter pylori in Latin America
Randomized controlled trial of biofeedback for fecal incontinence
Volume 150, Issue 4, Pages (April 2016)
Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States  Constance E. Ruhl, James E.
Kenneth E.L. McColl, Derek Gillen  Gastroenterology 
Volume 143, Issue 1, Pages e1 (July 2012)
A. Sidney Barritt, Michael W. Fried  Gastroenterology 
Gastric intestinal metaplasia on routine endoscopic biopsy
Update on the Use of Vonoprazan: A Competitive Acid Blocker
Angela Wong, Rebecca C. Fitzgerald 
Covering the Cover Gastroenterology
Postprandial Uridine Physiology Is Altered by Obesity
Omar Cauli, Mohammad T. Mansouri, Ana Agusti, Vicente Felipo 
Effect of antioxidants on the immune response of Helicobacter pylori
Barry Marshall 2005 Nobel Laureate in Medicine and Physiology
Colin Crooks, Tim Card, Joe West  Gastroenterology 
Vaccinating Against Helicobacter pylori: Dissecting the Mechanism
Volume 134, Issue 1, Pages (January 2008)
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger- Ellison syndrome: A 13-year prospective study  Basil I. Hirschowitz,
Volume 148, Issue 3, Pages (March 2015)
Volume 145, Issue 4, Pages (October 2013)
The Toronto Helicobacter pylori Consensus in Context
Volume 121, Issue 4, Pages (October 2001)
The Dawning of a New Editorial Board for Gastroenterology
Advances in Minimally Invasive Surgery
Changing of the Guards: 2011–2016 Gastroenterology Team
Liver Transplantation for Hepatocellular Carcinoma
Risks Associated With Anesthesia Services During Colonoscopy
Volume 148, Issue 4, Pages (April 2015)
Would Free Fatty Acids Enhance Treatment of Obesity?
Michelle Maria Pietzak  Gastroenterology 
Volume 155, Issue 6, Pages (December 2018)
Eradication Therapy for Helicobacter pylori
Volume 139, Issue 6, Pages e1 (December 2010)
Cancer Costs Projected to Reach at Least $158 Billion in 2020
Genetic testing: Who should do the testing and what is the role of genetic testing in the setting of celiac disease?  Edwin Liu, Marian Rewers, George.
Volume 135, Issue 5, Pages (November 2008)
Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis  Russell F. Jacoby, Carolyn E.
Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects  Paolo L. Peghini, Philip O. Katz, Donald.
Volume 119, Issue 2, Pages (August 2000)
Kimitoshi Kato, MD  Gastrointestinal Endoscopy 
Presentation transcript:

Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment  Derek Gillen, Angela A. Wirz, Kenneth E.L. McColl  Gastroenterology  Volume 126, Issue 4, Pages 980-988 (April 2004) DOI: 10.1053/j.gastro.2004.01.004

Figure 1 Submaximal acid output before, during, and at various time periods after stopping omeprazole in the 3 groups studied. Values are shown as percentage of pretreatment value (column 0), which is expressed as 100%. Column 1 is during treatment and colums 2, 3, 4, 5, and 6 represent days 7, 14, 28, 42, and 56, respectively, after stopping treatment. The horizontal bars indicate median values. Gastroenterology 2004 126, 980-988DOI: (10.1053/j.gastro.2004.01.004)

Figure 2 Maximal acid output before, during, and at various time periods after stopping omeprazole in the 3 groups studied. Values are shown as percentage of pretreatment value (column 0), which is expressed as 100%. Column 1 is during treatment and columns 2, 3, 4, 5, and 6 represent days 7, 14, 28, 42, and 56, respectively, after stopping treatment. The horizontal bars indicate median values. Gastroenterology 2004 126, 980-988DOI: (10.1053/j.gastro.2004.01.004)